How Type 2 Diabetes Affects the Brain

The results of studies on humans and zebrafish suggest how hyperglycemia can cause cognitive deficits.

Written byMallory Locklear
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

TOP: WIKIMEDIA, PATRICK J. LYNCH; BOTTOM: WIKIMEDIA, AZUL Reductions in both insulin production and an impaired physiological response to insulin release, which lead to elevated blood sugar, are hallmarks of type 2 diabetes. Less well-known are the cognitive effects of the metabolic disorder. “Diabetes does affect a number of cognitive domains, the main being executive functions, memory, learning, and concentration,” said Rodrigo Mansur, a psychiatry clinical and research fellow at the University of Toronto.

These effects aren’t always dramatic, explained Yong-Wook Shin, an associate professor of psychiatry at the University of Ulsan College of Medicine in South Korea. When it comes to the brain, he said, type 2 diabetes has “a subtle effect, but it can be detected.”

That type 2 diabetes can affect memory, learning, and concentration makes sense, according to computational cognitive neuroscientist Dae-Jin Kim of the Indiana University Bloomington. “Our brain consumes about 25 percent of the blood in our body,” he noted. “So, the glucose in our blood should affect our brain the most.”

Two recent studies have approached this diabetes-brain connection from different angles. The first, published last month (June 23) in PLOS ONE, examined brain communication in patients with poorly controlled type 2 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies